Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

European hospital information systems market to grow to $4.26bn by 2015

This article was originally published in Clinica

Executive Summary

The European hospital information systems market was worth over $3.4bn in 2008 and is expected to grow to $4.26bn by 2015, according to a report by Frost & Sullivan, published yesterday. "Government and regulatory authorities are compelled to increase investments into healthcare automation, due to political pressure as well as public demand," the authors believe. "Although most hospitals in Europe have some kind of information system in place, very few have a fully integrated and functional hospital information systems (HIS) solutions installed," they note. The adoption rate of HIS technology in 2008 is said to have varied from "about 73% in Italy and Spain, to 95% in Scandinavia". The report is titled Hospital information systems market in Europe.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT044194

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel